Therefore, overexpression of RCC2 in tumor cells prevents cellular apoptosis and promotes chemotherapeutic resistance by blocking Rac1 signaling (Figure 3) (Wu et al., 2018). The gene discussed is RAC1; the disease is neoplasm.